Deciphera Pharmaceuticals, Inc. announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy brings 20 years of life science leadership experience to the role, and her responsibilities will include developing and leading the Company's business development efforts as well as supporting corporate strategy initiatives. Ms. Dealhoy brings over 20 years of experience in the life science sector with a focus on driving innovation through strategic partnerships.

She joins Deciphera from Novartis, where she most recently served as the Vice President of Business Development for the Oncology Division. Ms. Dealhoy had a cumulative 10 years of experience at Novartis in a variety of roles including as Vice President of U.S. Business Development for the Pharmaceutical Division and Global Head of Business Development and M&A for the Consumer Division. Prior to Novartis, Ms. Dealhoy was a Life Science Leader in Deloitte's Financial Advisory practice where she worked with biotechnology and pharmaceutical companies to develop and implement strategies to drive growth and unlock value.

She has also held leadership roles in business development and R&D at Merck and Eli Lilly. She received her Bachelor of Science in Biochemistry from Queen's University in Canada.